Identifying survival predictors for breast cancer patients with and without HIV in South Africa
Novel predictors of survival among breast cancer patients with/without HIV in South Africa
This study is looking at how having HIV and taking HIV medicine might impact breast cancer treatment and recovery for women in South Africa, with the goal of finding better ways to help them survive and thrive.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wits Health Consortium (Pty), LTD NIH-funded |
| Lab location | 1 site (Parktown, South Africa) |
| Project ID | NIH-10851806 on NIH RePORTER |
What this research studies
This research investigates how HIV infection and antiretroviral therapy (ART) affect breast cancer treatment and outcomes among women in South Africa. By analyzing data from over 3,000 breast cancer patients, including those who are HIV positive, the study aims to identify factors that influence survival rates. The research builds on previous findings and seeks to improve understanding of the interplay between HIV and breast cancer, ultimately guiding better treatment strategies. Patients will be monitored for their clinical characteristics and treatment responses over time.
Who could benefit from this research
Good fit: Ideal candidates for this research include women diagnosed with breast cancer in South Africa, particularly those who are HIV positive.
Not a fit: Patients who do not have breast cancer or are not located in South Africa may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and treatment protocols for breast cancer patients living with HIV.
How similar studies have performed: Previous studies have shown promising results in understanding the relationship between HIV and breast cancer, indicating that this research builds on established findings.
Where this research is happening
Parktown, South Africa
- Wits Health Consortium (Pty), LTD — Parktown, South Africa (Active)
Researchers
- Principal investigator: Joffe, Maureen — Wits Health Consortium (Pty), LTD
- Study coordinator: Joffe, Maureen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.